Should Inflammation Be a Specifier for Major Depression in the <i>DSM-6</i>?
This Viewpoint discusses the opportunity to include inflammatory biomarkers as specifiers for major depression in the upcoming Sixth Edition of the Diagnostic and Statistical Manual of Mental Disorders ( DSM-6 ).
Authors
- Marion Leboyer (ORCID: https://orcid.org/0000-0001-5473-3697)
- Manish K. Jha (ORCID: https://orcid.org/0000-0002-2764-2391)
- Carmine M. Pariante (ORCID: https://orcid.org/0000-0002-9132-5091)
- Andrew H. Miller (ORCID: https://orcid.org/0009-0000-0426-0297)
Institutions
- Emory University (US)
- Inserm (FR)
- King's College London (GB)
- Université Paris-Est Créteil (FR)
- Fondation FondaMental (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- JAMA Psychiatry
- Published
- 2025-04-02
- DOI
- https://doi.org/10.1001/jamapsychiatry.2025.0206
- Citations
- 22
- Primary Topic
- Tryptophan and brain disorders
- Type
- article
- Field-Weighted Citation Impact
- 12.71